Cardiovascular disease (CVD) is the main cause of death and disability among people with type 2 diabetes.[2] Adults with type 2 diabetes are two to four times more likely to develop CVD than adults without diabetes.[3] The FDA's decision on semaglutide is based on results from the SUSTAIN 6 cardiovascular outcomes trial (CVOT), which examined the cardiovascular safety of adding Ozempic or placebo to standard-of-care in adults with type 2 diabetes and established cardiovascular disease
insufficient user instructions that led to an unexpected shutdown) while operating near an MRI," said FDA
Many patients come to us after purchasing peptides online from research chemical companies with no medical oversight
Chapter 182: Approach to the Patient with Cancer
View Study [6]"Expression and activation of matrix metalloproteinases in wounds: modulation by GHK-Cu" Simeon A, Monier F, Emonard H, Gillery P, et al., 1999 Finding: GHK-Cu was shown to intelligently regulate wound remodeling enzymes (MMPs)increasing them when needed for tissue restructuring and decreasing them to prevent excessive breakdown
Hims & Hers launched its weight loss program in December and recently added compounded GLP-1 medications to its offerings